Investing $1,000 in the Vanguard Dividend Appreciation ETF (VIG) is a smart choice for long-term growth. With a low expense ratio and a diversified portfolio of companies with a history of increasing dividends, VIG offers a reliable way to earn passive income. This ETF provides stability and potential for capital appreciation, making it a top pick for investors looking to build wealth over time.
Source link
Monthly weight loss drug helps people lose 20% of body weight, trial finds
Amgen's monthly weight loss drug MariTide demonstrated a 20% average body weight reduction in a phase 2 trial, positioning it as a potential competitor in the GLP-1 market dominated by Novo Nordisk and Eli Lilly. With added benefits like improved A1c levels and cardiovascular risk factors, MariTide aims for a phase 3 trial, highlighting advancements in diabetes and weight loss treatments. Need More Context? 🔎
Read more